| Predicate |
Object |
| contentType |
Editorial|Comment |
| endingPage |
17 |
| issn |
2218-6751
2226-4477 |
| issueIdentifier |
1 |
| pageRange |
13-17 |
| publicationName |
Translational Lung Cancer Research |
| startingPage |
13 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7 |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f10d10dbfc06ee94265f8d7e4f1eccd6 |
| bibliographicCitation |
Rengarajan M, Gainor JF. Endocrine immune-related adverse events: a double-edged sword? Transl Lung Cancer Res. 2021 Jan;10(1):13–7. PMID: 33569289; PMCID: PMC7867773. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0103c9f5e823f27b19c51abcafb125f6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9bf201c5e7a4839c9188d730361ae630 |
| date |
202101 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/33569289
https://pubmed.ncbi.nlm.nih.gov/PMC7867773
https://doi.org/10.21037/tlcr-2020-16 |
| isPartOf |
https://portal.issn.org/resource/ISSN/2218-6751
https://portal.issn.org/resource/ISSN/2226-4477
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43494 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Endocrine immune-related adverse events: a double-edged sword? |